Ask Bill Hearl About: ITI's Cancer Discovery Incubator
The Immunomic Therapeutics, Inc. Cancer Discovery Incubator will enable and accelerate beginning ventures with the capacity for measurable change in oncology health. The goal is to empower the beneficiary to conduct proof-of-concept experiments and ultimately, attract funding, partnerships, and fuel growth. Learn more about the incubator here and in the video above.
Jump into the BioHive on Friday, Dec. 2nd at 11 am as Bill will answer any and all questions you may have about the incubator including:
1. What kind of cancer discovery technologies is the incubator looking for?
2. Do the incubator goals fit in to Vice President Biden’s Cancer Moonshot initiative?
3. How is an industry incubator differentiated from an academic incubator?
4. What is Immunomic’s entrepreneurial story?